PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
$5.37−0.05 (-0.92%)
Close on Nov 18, 2026Market cap $57.65MP/E –Yield –
PharmaCyte Biotech free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
No free cash flow figures for PharmaCyte Biotech
PharmaCyte Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?